Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC). Am J Blood Res. 2013;3(3):225-38.
De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. Clin Immunol. 2015.
Leukocyte Adhesion Deficiency -A Multicenter National Experience. Eur J Clin Invest. 2018:e13047..
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2019.
The Broad Clinical Spectrum and Transplant Results of PNP Deficiency. J Clin Immunol. 2019..
Gram-negative Bacteremia in Children With Hematological Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome. J Pediatr Hematol Oncol. 2019..
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol. 2019.
Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. PLoS One. 2019;14(6):e0217572..
Characterization of the clinical and immunological phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020.
Ibrutinib treatment of pediatric chronic graft-versus-host disease: primary results from the phase 1/2 iMAGINE study. Transplant Cell Ther. 2022.
Lessons Learned from Five Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Israel. J Allergy Clin Immunol Pract. 2022.
Long term results with thiotepa containing regimen (TECAM) for autologous stem cell transplantation. Transplant Cell Ther. 2023..
Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines. J Invest Dermatol. 2023.